Quick Answer
RESMED INC reported Cash And Cash Equivalents At Carrying Value of $1.21 billion for the year ending 2025.
- RESMED INC showed an increase of +407.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from RESMED INC's annual report (Form 10-K), filed with the SEC on August 8, 2025.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), RESMED INC's Cash And Cash Equivalents At Carrying Value has grown by 191.0%.
- Historical annual values: Fiscal year 2025: $1.21 billion | Fiscal year 2024: $238.36 million | Fiscal year 2023: $227.89 million | Fiscal year 2022: $273.71 million | Fiscal year 2021: $295.28 million | Fiscal year 2020: $463.16 million | Fiscal year 2019: $147.13 million | Fiscal year 2018: $188.70 million | Fiscal year 2017: $821.94 million | Fiscal year 2016: $731.43 million | Fiscal year 2015: $717.25 million | Fiscal year 2014: $905.73 million | Fiscal year 2013: $876.05 million | Fiscal year 2012: $809.54 million | Fiscal year 2011: $735.27 million | Fiscal year 2010: $488.78 million | Fiscal year 2009: $415.65 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: